Pharmacological strategies for muscular dystrophy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
Duchenne muscular dystrophy (DMD) is a fatal, genetic disorder whose relentless progression underscores the urgency for developing a cure. Although Duchenne initiated clinical trials roughly 150 years ago, therapies for DMD remain supportive rather than curative. A paradigm shift towards developing rational therapeutic strategies occurred with identification of the DMD gene. Gene- and cell-based therapies designed to replace the missing gene and/or dystrophin protein have achieved varying degrees of success. However, pharmacological strategies not designed to replace dystrophin per se appear promising, and can circumvent many hurdles hampering gene- and cell-based therapy. Here, we will review present pharmacological strategies, in particular those dealing with functional substitution of dystrophin by utrophin and enhancing muscle progenitor commitment by myostatin blockade, with a view toward facilitating drug discovery for DMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Dystrophin expression in the mdx mouse restored by stem cell transplantation
Gussoni, E., Soneoka, Y., Strickland, C. D., Buzney, E. A., Khan, M. K., Flint, A. F., Kunkel, L. M., & Mulligan, R. C. (1999) · Nature · doi:10.1038/43919 · Cited by 1,802
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765
Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle
Grobet, L., Royo Martin, L. J., Poncelet, D., Pirottin, D., Brouwers, B., Riquet, J., Schoeberlein, A., Dunner, S., Ménissier, F., Massabanda, J., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-71 · Cited by 1,556
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
Koenig, M., Monaco, A. P., & Kunkel, L. M. (1988) · Cell · doi:10.1016/0092-8674(88)90383-2 · Cited by 1,538
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526
Membrane organization of the dystrophin-glycoprotein complex
Ervasti, J. M., & Campbell, K. P. (1991) · Cell · doi:10.1016/0092-8674(91)90035-w · Cited by 1,329
Research works printed but not linked: 3
- Duchenne, G. B. A. Recherches sur la paralysie musculaire pseudohypertrophique ou paralysie myo-sclerosique. Arch. Gen. Med. 11, 5–528 (1868).
- Engel, A. G. & Franzini-Armstrong, C. Myology (McGraw–Hill, New York, 1994).
- Bonifati, M. D. et al. A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 23, 1344–1347 (2000). · DOI · Paper page
Cited by
Items 101–200 of 226
Dogra, C., Srivastava, D. S., & Kumar, A. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9716-6 · Cited by 42
Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine
Wasala, N. B., Chen, S., & Duan, D. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1718100 · Cited by 40
Capote, J. C., DiFranco, M., & Vergara, J. L. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00428.2009 · Cited by 41
Translational Pharmacokinetic/Pharmacodynamic Analysis of MYO‐029 Antibody for Muscular Dystrophy
Singh, P., Rong, H., Gordi, T., Bosley, J., & Bhattacharya, I. (2016) · Clinical and Translational Science · doi:10.1111/cts.12420 · Cited by 40
Fallon, J. R., & McNally, E. M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.016 · Cited by 43
Novel cell-penetrating α-keto-amide calpain inhibitors as potential treatment for muscular dystrophy
Lescop, C., Herzner, H., Siendt, H., Bolliger, R., Henneböhle, M., Weyermann, P., Briguet, A., Courdier-Fruh, I., Erb, M., Foster, M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.064 · Cited by 37
Thyroid Hormone Action in Muscle Atrophy
Stefano, M. A. D., Ambrosio, R., Porcelli, T., Orlandino, G., Salvatore, D., & Luongo, C. (2021) · Metabolites · doi:10.3390/metabo11110730 · Cited by 47
Certo, M. G. D., Corbi, N., Strimpakos, G., Onori, A., Luvisetto, S., Severini, C., Guglielmotti, A., Batassa, E. M., Pisani, C., Floridi, A., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp539 · Cited by 35
Muskiewicz, K. R., Frank, N. Y., Flint, A., & Gussoni, E. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6573.2005 · Cited by 37
Gottlieb, P. A., Suchyna, T. M., & Sachs, F. (2007) · Current topics in membranes · doi:10.1016/s1063-5823(06)59004-0 · Cited by 32
Hindi, S. M., Sato, S., Choi, Y., & Kumar, A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt536 · Cited by 32
Blocking of Striated Muscle Degeneration by Serotonin in C. elegans
Carre-Pierrat, M., Mariol, M., Chambonnier, L., Laugraud, A., Heskia, F., Giacomotto, J., & Ségalat, L. (2006) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-006-9070-9 · Cited by 41
Loro, E., Sengupta, K., Bogdanovich, S., Whig, K., Schultz, D., Huryn, D. M., & Khurana, T. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-58737-6 · Cited by 33
Self-citationBaban, D. F., & Davies, K. E. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.11.011 · Cited by 37
Self-citationExpression of Myostatin and Follistatin inMdxMice, an Animal Model for Muscular Dystrophy
Abe, S., Soejima, M., Iwanuma, O., Saka, H., Matsunaga, S., Sakiyama, K., & Ide, Y. (2009) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.26.315 · Cited by 33
Péladeau, C. L., Ahmed, A., Amirouche, A., Parks, T. E. C., Bronicki, L., Ljubicic, V., Renaud, J., & Jasmin, B. J. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv444 · Cited by 34
Chiappalupi, S., Luca, G., Mancuso, F., Madaro, L., Fallarino, F., Nicoletti, C., Calvitti, M., Arato, I., Falabella, G., Salvadori, L., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.029 · Cited by 30
MicroRNA-206 Downregulation Improves Therapeutic Gene Expression and Motor Function in mdx Mice
Bulaklak, K., Xiao, B., Qiao, C., Li, J., Patel, T., Jin, Q., Li, J., & Xiao, X. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.05.011 · Cited by 29
Girgenrath, M., Kostek, C. A., & Miller, J. B. (2005) · BMC Neurology · doi:10.1186/1471-2377-5-7 · Cited by 27
Taguchi, A., Nishiguchi, S., Shiozuka, M., Nomoto, T., Ina, M., Nojima, S., Matsuda, R., Nonomura, Y., Kiso, Y., Yamazaki, Y., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200245t · Cited by 26
Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression
Péladeau, C. L., Adam, N., & Jasmin, B. J. (2018) · The FASEB Journal · doi:10.1096/fj.201800081r · Cited by 30
Endo, T. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.3.243 · Cited by 27
Altamirano, F. J., Pérez, C. F., Liu, M., Widrick, J. J., Barton, E. R., Allen, P. D., Adams, J. A., & Lopez, J. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106590 · Cited by 24
Targeting Artificial Transcription Factors to the Utrophin A Promoter
Lu, Y., Tian, C., Danialou, G., Gilbert, R., Petrof, B. J., Karpati, G., & Nalbantoglu, J. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804518200 · Cited by 24
Pre-clinical study of 21 approved drugs in the mdx mouse
Carre-Pierrat, M., Lafoux, A., Tanniou, G., Chambonnier, L., Divet, A., Fougerousse, F., Huchet, C., & Ségalat, L. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.01.005 · Cited by 24
Perkins, K. J., Basu, U., Budak, M. T., Ketterer, C., Baby, S. M., Lozynska, O., Lunde, J. A., Jasmin, B. J., Rubinstein, N. A., & Khurana, T. S. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1069 · Cited by 28
Self-citationThe role of myostatin and bone morphogenetic proteins in muscular disorders
Tsuchida, K. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.2.147 · Cited by 24
Baby, S. M., Bogdanovich, S., Willmann, G., Basu, U., Lozynska, O., & Khurana, T. S. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00275.x · Cited by 24
Self-citationHeregulin‐induced epigenetic regulation of the utrophin‐A promoter
Basu, U., Gyrd‐Hansen, M., Baby, S. M., Lozynska, O., Krag, T. O. B., Jensen, C. J., Frödin, M., & Khurana, T. S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.07.021 · Cited by 21
Self-citationThe importance of dystrophin and the dystrophin associated proteins in vascular smooth muscle
Kaplan, K. M., & Morgan, K. G. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1059021 · Cited by 20
Hinkle, R. T., Lefever, F. R., Dolan, E. T., Reichart, D. L., Dietrich, J., Gropp, K. E., Thacker, R. I., DeMuth, J. P., Stevens, P., Qu, X. A., et al. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-18 · Cited by 21
Onori, A., Pisani, C., Strimpakos, G., Monaco, L., Mattei, E., Passananti, C., & Corbi, N. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-3 · Cited by 22
Amali, A. A., Lin, C. J., Chen, Y., Wang, W.-L., Gong, H., Rekha, R. D., Lu, J., Chen, T. T., & Wu, J. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9250-2 · Cited by 20
Circulating myogenic progenitors and muscle repair
Long, M. A., Corbel, S. Y., & Rossi, F. M. V. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.07.001 · Cited by 20
Evidence for impaired neurovascular transmission in a murine model of Duchenne muscular dystrophy
Bagher, P., Duan, D., & Segal, S. S. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01106.2010 · Cited by 22
Moorwood, C., & Khurana, T. S. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.777040 · Cited by 18
Self-citationMorrison, L. A. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-08-045031-5.00002-5 · Cited by 17
Myostatin Regulates Tissue Potency and Cardiac Calcium-Handling Proteins
Jackson, M. F., Li, N., & Rodgers, B. D. (2014) · Endocrinology · doi:10.1210/en.2013-2014 · Cited by 18
Davies, K. E. (2013) · Clinical Medicine · doi:10.7861/clinmedicine.13-6-594 · Cited by 22
Self-citationStocksley, M. A., Chakkalakal, J. V., Bradford, A., Miura, P., Repentigny, Y. D., Kothary, R., & Jasmin, B. J. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2005.03.008 · Cited by 17
Onori, A., Desantis, A., Buontempo, S., Certo, M. G. D., Fanciulli, M., Salvatori, L., Passananti, C., & Corbi, N. (2007) · Biochemistry and Cell Biology · doi:10.1139/o07-015 · Cited by 17
Perkins, K. J., & Davies, K. E. (2018) · FEBS Letters · doi:10.1002/1873-3468.13099 · Cited by 16
Self-citationCurrent understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead
Zhou, G., Xie, H., Zhang, S., & Yang, Z. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200608020-00011 · Cited by 18
Deiodinases and stem cells: an intimate relationship
Salvatore, D. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0737-4 · Cited by 19
Gleneadie, H. J., Fernandez-Ruiz, B., Sardini, A., de Pette, M. V., Dimond, A., Prinjha, R. K., Mcginty, J. A., French, P. M. W., Bagci, H., Merkenschlager, M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04666-9 · Cited by 12
S-Nitrosation and Ubiquitin-Proteasome System Interplay in Neuromuscular Disorders
Rizza, S., Montagna, C., Giacomo, G. D., Cirotti, C., & Filomeni, G. (2014) · International Journal of Cell Biology · doi:10.1155/2014/428764 · Cited by 17
ADAM12 overexpression does not improve outcome in mice with laminin α2-deficient muscular dystrophy
Guo, L. T., Shelton, G. D., Wewer, U. M., & Engvall, E. (2005) · Neuromuscular Disorders · doi:10.1016/j.nmd.2005.06.019 · Cited by 14
Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice
Pereira, J. A., Taniguti, A. P. T., Matsumura, C. Y., Marques, M. J., & Neto, H. S. (2012) · Muscle & Nerve · doi:10.1002/mus.23331 · Cited by 12
Ramírez‐Sánchez, I., Ceballos, G. M., Rosas‐Vargas, H., Cerecedo, D., Zentella‐Dehesa, A., Salamanca, F., & Coral‐Vázquez, R. M. (2006) · Frontiers in bioscience · doi:10.2741/2201 · Cited by 12
Okadaic acid augments utrophin in myogenic cells
Rodova, M., Brownback, K. R., & Werle, M. J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.04.001 · Cited by 12
Desantis, A., Onori, A., Certo, M. G. D., Mattei, E., Fanciulli, M., Passananti, C., & Corbi, N. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.11.005 · Cited by 11
Modulation of Follistatin and Myostatin Propeptide by Anabolic Steroids and Gender
Mosler, S., Geisler, S., Hengevoß, J., Schiffer, T., Piechotta, M., Adler, M., & Diel, P. R. (2013) · International Journal of Sports Medicine · doi:10.1055/s-0032-1312585 · Cited by 10
Gurel, V., Lins, J., Lambert, K., Lazauski, J., Spaulding, J., & McMichael, J. C. (2015) · Dose-Response · doi:10.1177/1559325815616351 · Cited by 10
Pursuing effective Gram-negative antibiotics: The chemical synthesis of negamycin
Zhu, L., & Hong, R. (2018) · Tetrahedron Letters · doi:10.1016/j.tetlet.2018.04.059 · Cited by 10
Modeling inflammatory bowel disease: the zebrafish as a way forward
Love, D. R., Lan, C.-C., Dodd, A. W., Shelling, A. N., McNabb, W. C., & Ferguson, L. R. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.177 · Cited by 10
Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy
Mitchell, R., Frederick, N. E., Holzman, E., Agobe, F., Allaway, H. C. M., & Bagher, P. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00180.2021 · Cited by 9
Chiappalupi, S., Luca, G., Mancuso, F., Madaro, L., Fallarino, F., Nicoletti, C., Calvitti, M., Arato, I., Falabella, G., Salvadori, L., et al. (2015) · Data in Brief · doi:10.1016/j.dib.2015.11.016 · Cited by 9
Ghosh, T., & Basu, U. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134809 · Cited by 9
Polystyrene-coated micropallets for culture and separation of primary muscle cells
Detwiler, D. A., Dobes, N. C., Sims, C. E., Kornegay, J. N., & Allbritton, N. L. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5596-9 · Cited by 8
Endesfelder, S., Kliche, A., Lochmüller, H., von Moers, A., & Speer, A. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0607-3 · Cited by 8
Ruan, T., Harney, D., Koay, Y. C., Loo, L., Larance, M., & Caron, L. (2022) · Cells · doi:10.3390/cells11060963 · Cited by 7
Jyothish, K., & Roy, S. (2025) · ACS Omega · doi:10.1021/acsomega.4c08572 · Cited by 6
Diel, P. R., Schiffer, T., Geisler, S., Hertrampf, T., Mosler, S., Schulz, S., Wintgens, F., & Adler, M. (2010) · The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego · doi:10.1210/endo-meetings.2010.part1.p1.p1-45 · Cited by 6
Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice
Wu, M. P., & Gussoni, E. (2010) · Muscle & Nerve · doi:10.1002/mus.21785 · Cited by 6
Aquapuncture Using Stem Cell Therapy to Treat Mdx Mice
Esper, G. V. Z., Pignatari, G. C., Rodrigues, M. N., Bertagnon, H. G., Fernandes, I. R., do Nascimento, N., Tabosa, Â., Beltrão-Braga, P. C. B., & Miglino, M. A. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/132706 · Cited by 5
Novel Targets and Approaches to Treating Skeletal Muscle Disease
McNally, E. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00081-8 · Cited by 5
Stillwell, W. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63772-7.00022-1 · Cited by 6
Geneand cell-based therapy of muscle system hereditary disorders: state-of-art
Deev, R. V., Мавликеев, М. О., Bozo, I. Y., Pulin, A. A., & Eremin, I. I. (2014) · Genes and Cells · doi:10.23868/gc120368 · Cited by 5
Crunkhorn, S. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2857 · Cited by 4
Drug Discovery Approaches for Rare Neuromuscular Diseases
Wynne, G. M., & Russell, A. J. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782624202-00257 · Cited by 3
On the path to a Duchenne muscular dystrophy therapy.
Fallon, J. R. (2013) · PubMed · Cited by 3
Negamycin-therapy in Skeletal and Cardiac Muscles of mdx Mice
Arakawa, M., Shiozuka, M., Nakayama, Y., Hara, T., HAMADA, M., Ikeda, D., Takahashi, Y., Sawa, R., Nonomura, Y., Sheykholeslami, K., et al. (2003) · Cited by 3
Therapeutic Approaches for the Sarcomeric Protein Diseases
Nowak, K. J. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-84847-1_15 · Cited by 6
Davies, K. E., & Khurana, T. S. (2007) · Nature Medicine · doi:10.1038/nm0507-538 · Cited by 3
Self-citationAmir, M., Yimer, N., Hiew, M. W. H., Yusoff, M. S. M., Sadiq, M. B., & Quddus, A. (2025) · Biology · doi:10.3390/biology14020159 · Cited by 2
Ghosh, U., Bose, S., Ghosh, T., Bandyopadhyay, T. K., & Basu, U. (2015) · Analytical Biochemistry · doi:10.1016/j.ab.2015.02.018 · Cited by 2
The Application of RAGE and GECKO in Cell-Based Target Discovery Screens
Brunden, K., Sherf, B., & Harrington, J. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.4.383 · Cited by 2
Guerron, A. D., Rawat, R., Sali, A., Spurney, C. F., Pistilli, E. E., Cha, H., Pandey, G. S., Gernapudi, R., Francia, D., Farajian, V., et al. (2010) · PLoS ONE · doi:10.1371/annotation/ccf651e7-2e1d-494d-94cd-bb2fbffff4e7 · Cited by 2
Signaling Pathways Controlling Muscle Fiber Size and Type In Response To Nerve Activity
Schiaffino, S., Sandri, M., & Murgia, M. (2007) · Springer eBooks · doi:10.1007/1-4020-5177-8_4 · Cited by 2
Gene therapy approaches to the duchenne muscular dystrophy theatment
Zaynitdinova, M. I., Smirnikhina, S. A., Lavrov, A. V., Eremin, I. I., & Pulin, A. A. (2019) · Genes and Cells · doi:10.23868/201912026 · Cited by 4
Genetik menschlicher Erkrankungen
Graw, J. (2020) · Springer eBooks · doi:10.1007/978-3-662-60909-5_13 · Cited by 1
Zebrafish Assays for Identifying Potential Muscular Dystrophy Drug Candidates
Tang, J., Tang, S., Haldi, M., & Seng, W. L. (2011) · Zebrafish · doi:10.1002/9781118102138.ch18 · Cited by 1
Les copolymères à blocs pour le transfert de gènes dans le muscle squelettique
Richard, P. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Estudo da expressão da miostatina em modelos murinos para doenças neuromusculares.
Zilbersztajn, D. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.87.2011.tde-14092011-140119 · Cited by 2
Estudos moleculares e protéicos nas miopatias congênitas e distrofias musculares progressivas
Vainzof, M. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2011.tde-11102011-142915
Efeitos da mutação mdx no background 129/Sv
Calyjur, P. C. (2015) · doi:10.11606/d.41.2015.tde-17072015-142001
Guerron, A. D., Rawat, R., Sali, A., Spurney, C. F., Pistilli, E. E., Cha, H., Pandey, G. S., Gernapudi, R., Francia, D., Farajian, V., et al. (2010) · PLoS ONE · doi:10.1371/annotation/a82245dd-7379-4067-bd84-b0fc5ffb5869
dos Santos, A. L. F. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2012.tde-05022013-092744 · Cited by 2
Araújo, K. P. C. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2009.tde-04022011-081208 · Cited by 1
Signaling mechanisms in regenerative myogenesis.
Hindi, S. M. (2014) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/1740
Alterações morfofuncionais renais em cães Golden Retriever Distróficos (GRMD)
Gonçalves, N. J. N., Miglino, M. A., Morini, A. C., Martins, D. D. S., & Ambrósio, C. E. (2014) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2014000400014
Tissue Expression and Actin Binding of a Novel N‐Terminal Utrophin Isoform
Zuellig, R. A., Bornhauser, B. C., Amstutz, R., Constantin, B., & SCHAUB, M. C. (2011) · BioMed Research International · doi:10.1155/2011/904547
Regulation of the Structure and Function of Skeletal Muscle and Tendon by Myostatin.
Mendias, C. L. (2007) · Deep Blue (University of Michigan) · Cited by 2
Inherited Muscle Disease: Gene Therapy
Partridge, T. A. (2007) · Wiley eBooks · doi:10.1002/9780470015902.a0005753.pub2
Duchenne and Becker muscular dystrophy: implications for at-risk individuals
Erasmus, S. (2010) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Oliveira, P. C. G. O. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2009.tde-25052009-151201 · Cited by 3
Metadata
- Authors
- Khurana, T. S., & Davies, K. E.
- Affiliations
- University of Pennsylvania (US)
- University of Oxford (GB)
- Corresponding author
- Khurana, Tejvir S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-05-01
- Volume
- 2
- Issue
- 5
- Pages
- 379-390
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2090269652
- Cited by
- 225
- References
- 139
- Citations by year
- 2026: 1 · 2025: 4 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 9 · 2017: 4 · 2016: 5 · 2015: 12 · 2014: 12 · 2013: 10 · 2012: 11
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Muscular Dystrophy Association
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Keywords
- Duchenne muscular dystrophy, pharmacotherapy, dystrophin, utrophin, muscle progenitor cells, gene therapy, cell therapy, drug discovery, muscle regeneration
- MeSH terms
- Animals, Calcium, Cytoskeletal Proteins, Disease Models, Animal, Drug Evaluation, Preclinical, Homeostasis, Humans, Membrane Proteins, Muscular Dystrophies, Promoter Regions, Genetic, Drug Design, Dystrophin, Utrophin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.